| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
TEG Trauma
Test Code35334
CPT Codes
85347; 85390; 85576; 85384
Includes
CK assay, Kaolin-activated test methods are used to reduce variability and to reduce the running time of a native whole blood sample.
The CRT assay maximally accelerates the clotting process by simultaneously activating the intrinsic and extrinsic coagulation pathways, allowing for the maximum clot strength to be reached more quickly.
The CFF assay inhibits the platelets, excluding their contribution to clot strength, and therefore measures only the functional fibrinogen contribution to the clot strength.
The CRT assay maximally accelerates the clotting process by simultaneously activating the intrinsic and extrinsic coagulation pathways, allowing for the maximum clot strength to be reached more quickly.
The CFF assay inhibits the platelets, excluding their contribution to clot strength, and therefore measures only the functional fibrinogen contribution to the clot strength.
Preferred Specimen
Blue top (Sodium citrate)
Minimum Volume
2.7 mL
Instructions
DO NOT SPIN
Specimen Stability
2 hours
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Spun tubes, short tubes, clots, hemolysis, and hemodilution
Methodology
Clot formation
Setup Schedule
Monday through Sunday
Clinical Significance
The TEG 6s Hemostasis Analyzer is intended for in vitro diagnostic use to monitor and analyze the coagulation state of a blood sample. The TEG 6s analyzer records the kinetic changes in a sample of anticoagulated whole blood as the sample clots, retracts and/or lyses in real time. The system output consists of a table of numeric values derived from a graphical representation of the hemostasis curve, which depicts clot firmness over time.
Performed By
CoxHealth
Performing Laboratory
CoxHealth
